These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of pathogenic B-cell clones in antibody mediated autoimmune disorders. Wang J; Zhu X J Dermatol Sci; 2004 Dec; 36(3):141-8. PubMed ID: 15541635 [TBL] [Abstract][Full Text] [Related]
3. B cell biology, apoptosis, and autoantibodies to phospholipids. Cook MC Thromb Res; 2004; 114(5-6):307-19. PubMed ID: 15507260 [TBL] [Abstract][Full Text] [Related]
4. B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target. Dalakas MC Pharmacol Ther; 2006 Oct; 112(1):57-70. PubMed ID: 16644016 [TBL] [Abstract][Full Text] [Related]
5. Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B cell selection and activation. Holers VM; Kulik L Mol Immunol; 2007 Jan; 44(1-3):64-72. PubMed ID: 16876864 [TBL] [Abstract][Full Text] [Related]
6. [Mechanisms of production and pathogenesis of autoantibodies]. Mimori T Rinsho Shinkeigaku; 2007 Nov; 47(11):855-7. PubMed ID: 18210817 [TBL] [Abstract][Full Text] [Related]
7. B cell-directed therapies for autoimmune disease and correlates of disease response and relapse. Levesque MC; St Clair EW J Allergy Clin Immunol; 2008 Jan; 121(1):13-21; quiz 22-3. PubMed ID: 18206502 [TBL] [Abstract][Full Text] [Related]
9. A possible new bridge between innate and adaptive immunity: Are the anti-mitochondrial citrate synthase autoantibodies components of the natural antibody network? Czömpöly T; Olasz K; Simon D; Nyárády Z; Pálinkás L; Czirják L; Berki T; Németh P Mol Immunol; 2006 Apr; 43(11):1761-8. PubMed ID: 16368144 [TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of autoimmunity. Atassi MZ; Casali P Autoimmunity; 2008 Mar; 41(2):123-32. PubMed ID: 18324481 [TBL] [Abstract][Full Text] [Related]
11. B cell targeted therapy in autoimmunity. Blank M; Shoenfeld Y J Autoimmun; 2007; 28(2-3):62-8. PubMed ID: 17391915 [TBL] [Abstract][Full Text] [Related]
12. Regulation of autoreactive B cells: checkpoints and activation. Ding C; Yan J Arch Immunol Ther Exp (Warsz); 2007; 55(2):83-9. PubMed ID: 17347802 [TBL] [Abstract][Full Text] [Related]
13. B cells and autoimmune liver diseases. Moritoki Y; Lian ZX; Ohsugi Y; Ueno Y; Gershwin ME Autoimmun Rev; 2006 Aug; 5(7):449-57. PubMed ID: 16920571 [TBL] [Abstract][Full Text] [Related]
15. Molecular mapping of autoimmune B cell responses in experimental myocarditis. Krebs P; Kurrer MO; Kremer M; De Giuli R; Sonderegger I; Henke A; Maier R; Ludewig B J Autoimmun; 2007 Jun; 28(4):224-33. PubMed ID: 17336498 [TBL] [Abstract][Full Text] [Related]
16. Targeting of B cells in SLE: rationale and therapeutic opportunities. Silverman GJ Bull NYU Hosp Jt Dis; 2006; 64(1-2):51-6. PubMed ID: 17121490 [TBL] [Abstract][Full Text] [Related]
18. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells. Dörner T J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439 [TBL] [Abstract][Full Text] [Related]
19. Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications. Lazzerini PE; Capecchi PL; Guideri F; Acampa M; Selvi E; Bisogno S; Galeazzi M; Laghi-Pasini F Basic Res Cardiol; 2008 Jan; 103(1):1-11. PubMed ID: 17999027 [TBL] [Abstract][Full Text] [Related]
20. Interleukin 21 as a target of intervention in autoimmune disease. Ettinger R; Kuchen S; Lipsky PE Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii83-6. PubMed ID: 19022821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]